133 related articles for article (PubMed ID: 27533001)
1. In vitro detection of human breast cancer cells (SK-BR3) using herceptin-conjugated liquid crystal microdroplets as a sensing platform.
Ding W; Gupta KC; Park SY; Kim YK; Kang IK
Biomater Sci; 2016 Oct; 4(10):1473-84. PubMed ID: 27533001
[TBL] [Abstract][Full Text] [Related]
2. The role of ligand-receptor interactions in visual detection of HepG2 cells using a liquid crystal microdroplet-based biosensor.
Choi Y; Lee K; Gupta KC; Park SY; Kang IK
J Mater Chem B; 2015 Nov; 3(44):8659-8669. PubMed ID: 32262723
[TBL] [Abstract][Full Text] [Related]
3. Folate ligand anchored liquid crystal microdroplets emulsion for in vitro detection of KB cancer cells.
Yoon SH; Gupta KC; Borah JS; Park SY; Kim YK; Lee JH; Kang IK
Langmuir; 2014 Sep; 30(35):10668-77. PubMed ID: 25121826
[TBL] [Abstract][Full Text] [Related]
4. Anti-IgG-anchored liquid crystal microdroplets for label free detection of IgG.
Lee K; Gupta KC; Park SY; Kang IK
J Mater Chem B; 2016 Jan; 4(4):704-715. PubMed ID: 32262952
[TBL] [Abstract][Full Text] [Related]
5. In vitro detection of allergen sensitized basophils by HSA-DNP antigen-anchored liquid crystal microdroplets.
Shin H; Park SJ; Gupta KC; Lee DY; Park SY; Kang IK
Anal Biochem; 2018 Oct; 558():1-11. PubMed ID: 30075101
[TBL] [Abstract][Full Text] [Related]
6. Internalization: acute apoptosis of breast cancer cells using herceptin-immobilized gold nanoparticles.
Rathinaraj P; Al-Jumaily AM; Huh DS
Breast Cancer (Dove Med Press); 2015; 7():51-8. PubMed ID: 25709498
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
[TBL] [Abstract][Full Text] [Related]
8. A new application of plant virus nanoparticles as drug delivery in breast cancer.
Esfandiari N; Arzanani MK; Soleimani M; Kohi-Habibi M; Svendsen WE
Tumour Biol; 2016 Jan; 37(1):1229-36. PubMed ID: 26286831
[TBL] [Abstract][Full Text] [Related]
9. Interfacial Polyelectrolyte-Surfactant Complexes Regulate Escape of Microdroplets Elastically Trapped in Thermotropic Liquid Crystals.
Tsuei M; Sun H; Kim YK; Wang X; Gianneschi NC; Abbott NL
Langmuir; 2022 Jan; 38(1):332-342. PubMed ID: 34967209
[TBL] [Abstract][Full Text] [Related]
10. Microfluidic formation of pH responsive 5CB droplets decorated with PAA-b-LCP.
Khan W; Choi JH; Kim GM; Park SY
Lab Chip; 2011 Oct; 11(20):3493-8. PubMed ID: 21874196
[TBL] [Abstract][Full Text] [Related]
11. Configuration change of liquid crystal microdroplets coated with a novel polyacrylic acid block liquid crystalline polymer by protein adsorption.
Khan W; Park SY
Lab Chip; 2012 Nov; 12(21):4553-9. PubMed ID: 22964831
[TBL] [Abstract][Full Text] [Related]
12. Design of peptidomimetics for inhibition of HER2 receptor dimerization by a combination of virtual screening, MD simulations, and QSAR in silico methods.
Jamalan M; Zeinali M; Barzegari Asadabadi E
Chem Biol Drug Des; 2013 Apr; 81(4):455-62. PubMed ID: 23006820
[TBL] [Abstract][Full Text] [Related]
13. Upregulated HSP27 in human breast cancer cells reduces Herceptin susceptibility by increasing Her2 protein stability.
Kang SH; Kang KW; Kim KH; Kwon B; Kim SK; Lee HY; Kong SY; Lee ES; Jang SG; Yoo BC
BMC Cancer; 2008 Oct; 8():286. PubMed ID: 18834540
[TBL] [Abstract][Full Text] [Related]
14. Biological evaluation of a novel Herceptin-platinum (II) conjugate for efficient and cancer cell specific delivery.
Huang R; Sun Y; Zhang XY; Sun BW; Wang QC; Zhu J
Biomed Pharmacother; 2015 Jul; 73():116-22. PubMed ID: 26211591
[TBL] [Abstract][Full Text] [Related]
15. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells.
Reim F; Dombrowski Y; Ritter C; Buttmann M; Häusler S; Ossadnik M; Krockenberger M; Beier D; Beier CP; Dietl J; Becker JC; Hönig A; Wischhusen J
Cancer Res; 2009 Oct; 69(20):8058-66. PubMed ID: 19826050
[TBL] [Abstract][Full Text] [Related]
16. Herceptin conjugated PLGA-PHis-PEG pH sensitive nanoparticles for targeted and controlled drug delivery.
Zhou Z; Badkas A; Stevenson M; Lee JY; Leung YK
Int J Pharm; 2015 Jun; 487(1-2):81-90. PubMed ID: 25865568
[TBL] [Abstract][Full Text] [Related]
17. Pharmacological blockade of fatty acid synthase (FASN) reverses acquired autoresistance to trastuzumab (Herceptin by transcriptionally inhibiting 'HER2 super-expression' occurring in high-dose trastuzumab-conditioned SKBR3/Tzb100 breast cancer cells.
Vazquez-Martin A; Colomer R; Brunet J; Menendez JA
Int J Oncol; 2007 Oct; 31(4):769-76. PubMed ID: 17786307
[TBL] [Abstract][Full Text] [Related]
18. Real-time, quantitative and sensitive detection of urea by whispering gallery mode lasing in liquid crystal microdroplet.
Duan R; Li Y; Shi B; Li H; Yang J
Talanta; 2020 Mar; 209():120513. PubMed ID: 31892099
[TBL] [Abstract][Full Text] [Related]
19. Herceptin-directed nanoparticles activated by an alternating magnetic field selectively kill HER-2 positive human breast cells in vitro via hyperthermia.
Zhang J; Dewilde AH; Chinn P; Foreman A; Barry S; Kanne D; Braunhut SJ
Int J Hyperthermia; 2011; 27(7):682-97. PubMed ID: 21992561
[TBL] [Abstract][Full Text] [Related]
20. Antihuman epidermal growth factor receptor 2 antibody herceptin inhibits autocrine motility factor (AMF) expression and potentiates antitumor effects of AMF inhibitors.
Talukder AH; Bagheri-Yarmand R; Williams RR; Ragoussis J; Kumar R; Raz A
Clin Cancer Res; 2002 Oct; 8(10):3285-9. PubMed ID: 12374700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
